|
Name |
Victoxinine
|
Molecular Formula | C17H29NO | |
IUPAC Name* |
2-[(1R,3S,7R,8S,9S)-1-methyl-2-methylidene-9-propan-2-yl-5-azatricyclo[5.4.0.03,8]undecan-5-yl]ethanol
|
|
SMILES |
CC(C)[C@@H]1CC[C@@]2([C@H]3[C@@H]1[C@@H](C2=C)CN(C3)CCO)C
|
|
InChI |
InChI=1S/C17H29NO/c1-11(2)13-5-6-17(4)12(3)14-9-18(7-8-19)10-15(17)16(13)14/h11,13-16,19H,3,5-10H2,1-2,4H3/t13-,14+,15+,16-,17-/m0/s1
|
|
InChIKey |
DROLRDZYPMOKLM-BIVLZKPYSA-N
|
|
Synonyms |
Victoxinine; 39965-06-5; 6YL9G51E97; 2-[(1R,3S,7R,8S,9S)-1-methyl-2-methylidene-9-propan-2-yl-5-azatricyclo[5.4.0.03,8]undecan-5-yl]ethanol; VICTOXININE, (+)-; UNII-6YL9G51E97; DTXSID10960469; 2-[8-Methyl-9-methylidene-5-(propan-2-yl)octahydro-4,8-methanoisoquinolin-2(1H)-yl]ethan-1-ol; 4,8-METHANOISOQUINOLINE-2(1H)-ETHANOL, OCTAHYDRO-8-METHYL-9-METHYLENE-5-(1-METHYLETHYL)-, (4.ALPHA.,4A.BETA.,5.ALPHA.,8.ALPHA.,8A.BETA.)-; 4,8-METHANOISOQUINOLINE-2(1H)-ETHANOL, OCTAHYDRO-8-METHYL-9-METHYLENE-5-(1-METHYLETHYL)-, (4R,4AR,5R,8R,8AS)-REL-(+)-
|
|
CAS | 39965-06-5 | |
PubChem CID | 181648 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 263.4 | ALogp: | 3.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 23.5 | Aromatic Rings: | 3 |
Heavy Atoms: | 19 | QED Weighted: | 0.787 |
Caco-2 Permeability: | -4.565 | MDCK Permeability: | 0.00001050 |
Pgp-inhibitor: | 0.014 | Pgp-substrate: | 0.52 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.032 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.987 | Plasma Protein Binding (PPB): | 46.77% |
Volume Distribution (VD): | 1.253 | Fu: | 56.34% |
CYP1A2-inhibitor: | 0.144 | CYP1A2-substrate: | 0.122 |
CYP2C19-inhibitor: | 0.033 | CYP2C19-substrate: | 0.926 |
CYP2C9-inhibitor: | 0.034 | CYP2C9-substrate: | 0.091 |
CYP2D6-inhibitor: | 0.076 | CYP2D6-substrate: | 0.815 |
CYP3A4-inhibitor: | 0.155 | CYP3A4-substrate: | 0.663 |
Clearance (CL): | 10.692 | Half-life (T1/2): | 0.322 |
hERG Blockers: | 0.225 | Human Hepatotoxicity (H-HT): | 0.465 |
Drug-inuced Liver Injury (DILI): | 0.144 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.817 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.361 | Carcinogencity: | 0.127 |
Eye Corrosion: | 0.71 | Eye Irritation: | 0.182 |
Respiratory Toxicity: | 0.975 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001293 | 0.574 | D04CSZ | 0.266 | ||||
ENC003488 | 0.492 | D0Y7LD | 0.227 | ||||
ENC001878 | 0.485 | D08SVH | 0.218 | ||||
ENC002277 | 0.463 | D0K5WS | 0.215 | ||||
ENC004835 | 0.463 | D04VIS | 0.212 | ||||
ENC005456 | 0.443 | D0B4RU | 0.208 | ||||
ENC002553 | 0.431 | D05BTM | 0.207 | ||||
ENC000535 | 0.368 | D0T2PL | 0.207 | ||||
ENC003050 | 0.366 | D0K0EK | 0.207 | ||||
ENC003649 | 0.351 | D0G3SH | 0.206 |